A 6-Week Treatment Regimen Study to Evaluate the Efficacy of Initial High Dose Valsartan Monotherapy (160 mg) or Combo Therapy (Valsartan + Hydrochlorothiazide, 160/12.5 mg) to Conventional Low-Dose Valsartan Monotherapy (80 mg) in Managing Patients With Hypertension
Latest Information Update: 18 Feb 2010
Price :
$35 *
At a glance
- Drugs Valsartan (Primary) ; Valsartan/hydrochlorothiazide (Primary)
- Indications Hypertension
- Focus Biomarker; Therapeutic Use
- Acronyms VELOCITY
- 05 Nov 2009 Primary endpoint 'Systolic blood pressure' has been met according to results published in the Journal of Human Hypertension.
- 20 Dec 2006 Status change
- 30 Mar 2006 New trial record.